Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.

WormBase Tree Display for Gene: WBGene00008877

expand all nodes | collapse all nodes | view schema

Name Class

WBGene00008877SMapS_parentSequenceF16A11
IdentityVersion2
NameCGC_namertcb-1Person_evidenceWBPerson236
Sequence_nameF16A11.2
Molecular_nameF16A11.2a
F16A11.2a.1
CE23663
F16A11.2b
Other_nameCELE_F16A11.2Accession_evidenceNDBBX284601
Public_namertcb-1
DB_infoDatabase (12)
SpeciesCaenorhabditis elegans
HistoryVersion_change126 May 2004 16:54:49WBPerson1971EventImportedInitial conversion from CDS class of WS125
228 Jan 2015 11:26:55WBPerson2970Name_changeCGC_namertcb-1
StatusLive
Gene_info (10)
Disease_infoExperimental_modelDOID:14330Homo sapiensPaper_evidenceWBPaper00031384
WBPaper00046051
Curator_confirmedWBPerson324
Date_last_updated24 Jul 2013 00:00:00
Disease_relevanceIn an elegans model of Parkinson''s disease, where human alpha-synuclein was overexpressed, RNA interference studies showed that the elegans rtcb-1 (contains an RNA-binding motif, ortholog to human HSPC117 protein, a component of RNA trafficking granules in neurons), significantly protected against age- and dose-dependent degeneration in the dopamine neurons of transgenic worms; further the RNA ligase activity of rtcb-1 is required for neuroprotection, which is mediated via the splicing of the xbp-1/HAC1 mRNA in the unfolded protein response pathway; this model highlights the intersection of RNA processing and proteostasis in mediating neuroprotection; it also allows the identification of human modifier proteins of alpha-synuclein dependent misfolding and neurodegeneration, these proteins may also be new potential targets for therapeutic intervention.Homo sapiensPaper_evidenceWBPaper00031384
WBPaper00046051
Curator_confirmedWBPerson324
Date_last_updated04 Feb 2015 00:00:00
Models_disease_in_annotationWBDOannot00000215
Molecular_infoCorresponding_CDSF16A11.2a
Corresponding_transcriptF16A11.2b
F16A11.2a.1
Other_sequence (89)
Experimental_infoRNAi_resultWBRNAi00003394Inferred_automaticallyRNAi_primary
WBRNAi00025118Inferred_automaticallyRNAi_primary
WBRNAi00076309Inferred_automaticallyRNAi_primary
WBRNAi00065397Inferred_automaticallyRNAi_primary
WBRNAi00025117Inferred_automaticallyRNAi_primary
WBRNAi00044772Inferred_automaticallyRNAi_primary
WBRNAi00008148Inferred_automaticallyRNAi_primary
WBRNAi00116595Inferred_automaticallyRNAi_primary
Expr_patternChronogram686
Expr5773
Expr12080
Expr12738
Expr1018785
Expr1033870
Expr1148737
Expr2015570
Expr2033805
Drives_constructWBCnstr00003232
Construct_productWBCnstr00006218
WBCnstr00006225
WBCnstr00019835
WBCnstr00020144
WBCnstr00022738
WBCnstr00022739
Microarray_results (17)
Expression_cluster (96)
InteractionWBInteraction000242604
WBInteraction000288404
WBInteraction000330452
WBInteraction000370713
WBInteraction000444571
WBInteraction000524592
Map_infoMapIPosition3.75935
PositivePositive_cloneF16A11Inferred_automaticallyFrom sequence, transcript, pseudogene data
Pseudo_map_position
Reference (13)
RemarkMap position created from combination of previous interpolated map position (based on known location of sequence) and allele information. Therefore this is not a genetic map position based on recombination frequencies or genetic experiments. This was done on advice of the CGC.CGC_data_submission
MethodGene